Tags : Pelle Pharma

Leo Pharma Collaborates with PellePharm for the Development of Drug

Vartika Singh November 21, 2018

Shots: Leo Pharma to invest $70M as equity investment in Pelle with R&D support to initiate P-III trial for Patidegib globally. Leo Pharma has an option to acquire Pelle, in […]readmore

Tags : Pelle Pharma

Leo Pharma Collaborates with PellePharm for the Development of Drug

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Company

Tags : Pelle Pharma

Leo Pharma Collaborates with PellePharm for the Development of Drug

Latest Posts

PharmaShots Weekly Snapshots (November 15 – 19, 2021)

Jazz’ Sunosi (solriamfetol) Receives NICE Recommendation for the Treatment of Excessive Daytime Sleepiness Caused by Narcolepsy

Antengene’s Selinexor (ATG-010) Receives NMPA’s IND Approval for P-I/II SWATCH Study to Treat Non-Hodgkin Lymphoma

Daiichi Sankyo Reports Results of Quizartinib in P-III QuANTUM-First Trial for the Treatment of FLT3-ITD Positive AML

Categories

Related Topics

Company